Peripherally inserted central catheters (PICCs) in cancer patients under chemotherapy: A prospective study on the incidence of complications and overall failures

Journal of Surgical Oncology

Volumn 113, Issue 6, 2016, Pages 708-714

  Bertoglio, Sergio ^a,b   Faccini, Beatrice ^b   Lalli, Luca ^b   Cafiero, Ferdinando ^b   Bruzzi, Paolo ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

CLABSI; complications; deep vein thrombosis; PICC; venous access device

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BASILIC VEIN; BRACHIAL VEIN; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CATHETER COMPLICATION; CATHETER DISLODGMENT; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER REMOVAL; CATHETER THROMBOSIS; COHORT ANALYSIS; COLON CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT FAILURE; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN; ADVERSE EFFECTS; AGED; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; DEVICE FAILURE; DEVICE REMOVAL; DEVICES; INDWELLING CATHETER; MIDDLE AGED; NEOPLASMS; PROCEDURES; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETER OBSTRUCTION; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; DEVICE REMOVAL; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES;

EID: 84962338761     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24220     Document Type: Article

References (33)

1. Schiefer CA, Mangu PB, Wade JC, et al.,: Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013; 31: 1357-1370.
2. Turcotte S, Dubè S, Beauchamp G,: Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward. World J Surg 2006; 30: 1605-1619.
3. Viart H, Combe C, Martinelli T, et al.,: Comparison between implantation costs of peripherally inserted central catheter and implanted subcutaneous ports. Ann Pharm Fr 2015; 73: 239-244.
4. Patel GS, Jain K, Kumar R, et al.,: Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Support Care Cancer 2014; 22: 121-128.
5. Cotogni P, Barbero C, Garrino C, et al.,: Peripherally inserted central catheters in non-hospitalized cancer patients: 5-year results of a prospective study. Support Care Cancer 2015; 23: 403-409.
6. Chopra V, Anand S, Hickner A, et al.,: Risk of venous thromboembolism associated with peripherally inserted central catheters: A systematic review and meta-Analysis. Lancet 2013; 382: 311-325.
7. Chopra V, Ratz D, Kuhn L, et al.,: Peripherally inserted central catheter-related deep vein thrombosis: Contemporary patterns and predictors. J Thromb Haemost 2014; 12: 847-854.
8. Lobo BL, Vaidean G, Broyles J, et al.,: Risk of venous thromboembolism in hospitalized cancer patients with peripherally inserted central catheters. J Hosp Med 2009; 4: 417-422.
9. Cheong K, Perry D, Karapetis C, et al.,: High rates of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Int Med J 2004; 34: 234-238.
10. Leung A, Heal C, Perera M, et al.,: A systematic review of patient-related risk factors for catheter related thrombosis. J Thromb Thrombolysis 2015; 40: 363-373 [Epub ahead of print].
11. Fallouh N, McGuirk HM, Flanders SA, et al.,: Peripherally inserted central-catheter associated deep vein thrombosis: A narrative review. Am J Med 2015; 128: 722-738.
12. Aw A, Carrier M, Koczerginski J, et al.,: Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res 2012; 130: 323-326.
13. Yi XL, Chen J, Li J, et al.,: Risk factors associated with PICC-related upper extremity venous thrombosis in cancer patients. J Clin Nurs 2013; 23: 837-843.
14. Ahn DH, Illum HB, Wang DH, et al.,: Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: A retrospective analysis of risk factors. J Oncol Pract 2013; 9: e8-12.
15. Qiu XX, Guo Y, Fan HB, et al.,: Incidence, risk factors and clinical outcomes of peripherally inserted central catheter spontaneous dislodgement in oncology patients: A prospective cohort study. Int J Nurs Stud 2014; 51: 955-963.
16. Liu Y, Gao Y, Wei L, et al.,: Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: A double-center prospective investigation. Ther Clin Risk Manag 2015; 11: 153-160.
17. Sperry BW, Roskos M, Oskoui R,: The effect of laterality on venous thromboembolism formation after peripherally inserted central catheter placement. J Vasc Access 2012; 13: 91-95.
18. Lyman GH, Khorana AA, Kuderer NM, et al.,: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31: 2189-2204.
19. Nifong TP, McDevitt TJ,: The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest 2011; 140: 48-53.
20. Bertoglio S, Solari N, Meszaros P, et al.,: Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs 2012; 35: E35-E42.
21. Bertoglio S, Rezzo R, Merlo FD, et al.,: Pre-filled normal saline syringes to reduce totally implantable venous access device-Associated bloodstream infection: A single institution pilot study. J Hosp Infect 2013; 84: 85-88.
22. O'Grady NP, Alexander M, Burns LA, et al.,: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39: S1-34.
23. Francis CW, Kessler CM, Goldhaber SZ, et al.,: Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: The DALTECAN Study. J Thromb Haemost 2015; 13: 1028-1035.
24. Narducci F, Jean-Laurent M, Boulanger S, et al.,: Totally implantable port systems and risk factors for complications: A one year prospective study in a cancer center. Eur J Surg Oncol 2011; 37: 913-918.
25. Sundriyal D, Shirsi N, Kapoor R, et al.,: Peripherally inserted central catheters: Our experience from a cancer research center. Indian J Surg Oncol 2014; 5: 274-277.
26. Sriskandarajah P, Webb K, Chisholm D, et al.,: Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. Thromb J 2015; 13: 21.
27. Meyer BM,: Managing peripherally inserted central catheter thrombosis risk: A guide for clinical best practice. J Ass Vasc Access 2011; 16: 144-147.
28. Chopra V, Ratz D, Kuhn L, et al.,: PICC-Associated bloodstream infections: Prevalence, patterns, and predictors. Am J Med 2014; 127: 319-328.
29. Ruiz-Santana S, Saavedra P, Leon C,: " Near zero"catheter-related bloodstream infection: Turning dreams into reality. Crit Care Med 2012; 40: 3083-3084.
30. Evans RS, Sharp JH, Linford LH, et al.,: Reduction of peripherally inserted central catheter-Associated DVT. Chest 2013; 143: 627-633.
31. O'Brien J, Paquet F, Lindsay R, et al.,: Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol 2013; 10: 864-868.
32. Verso M, Agnelli G, Kamphuisen PW, et al.,: Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med 2008; 3: 117-122.
33. Mori Y, Nagayama S, Kawamura J, et al.,: A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. Int J Clin Oncol 2015; 1-9 [Epub ahead of print].